Schizophrenia drug says goodbye to dopamine

Comment

Daniel R Weinberger. Nat Med. 2007 Sep.

. 2007 Sep;13(9):1018-9.

doi: 10.1038/nm0907-1018.

No abstract available

Comment in

Glutamate agonists for schizophrenia stimulate dopamine D2High receptors.
Seeman P. Seeman P. Schizophr Res. 2008 Feb;99(1-3):373-4. doi: 10.1016/j.schres.2007.11.007. Schizophr Res. 2008. PMID: 18077139 No abstract available.

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD. Patil ST, et al. Nat Med. 2007 Sep;13(9):1102-7. doi: 10.1038/nm1632. Epub 2007 Sep 2. Nat Med. 2007. PMID: 17767166 Clinical Trial.